Inmune Bio Inc (INMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,556 | -12,099 | -8,895 | -4,178 | -2,070 |
| Other Working Capital | -1,435 | 44 | -65 | -38 | 353 |
| Other Operating Activity | 899 | 3,112 | 2,409 | 1,363 | 682 |
| Operating Cash Flow | $-5,092 | $-8,943 | $-6,551 | $-2,853 | $-1,035 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 28,464 | 24,907 | 24,907 | 1,667 | 1,003 |
| Common Stock Repurchased | N/A | -1,012 | -1,012 | -1,012 | -1,012 |
| Financing Cash Flow | $28,464 | $23,895 | $23,895 | $655 | $-9 |
| Exchange Rate Effect | 1 | 19 | -29 | 18 | -21 |
| Beginning Cash Position | 21,967 | 6,996 | 6,996 | 6,996 | 6,996 |
| End Cash Position | 45,340 | 21,967 | 24,311 | 4,816 | 5,931 |
| Net Cash Flow | $23,373 | $14,971 | $17,315 | $-2,180 | $-1,065 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,092 | -8,943 | -6,551 | -2,853 | -1,035 |
| Free Cash Flow | -5,092 | -8,943 | -6,551 | -2,853 | -1,035 |